The University of Oxford â€™s Brazilian trial of its vaccine candidate will continue after the death of a volunteer , the university said on Wednesday , adding an independent review had revealed no safety concerns . 
" Following careful assessment of this case in Brazil , there have been no concerns about safety of the clinical trial and the independent review in addition to the Brazilian regulator have recommended that the trial should continue , " a spokesman for the university said in a statement . 
The deceased trial volunteer did not receive the vaccine , Bloomberg is reporting , citing a person familiar with the matter . 
The vaccine has been licensed to Astra Zeneca . 
